|
|
Volumn 374, Issue 9691, 2009, Pages 681-682
|
|
Rivaroxaban versus enoxaparin after total knee arthroplasty
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 10;
ENOXAPARIN;
RIVAROXABAN;
THROMBIN;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A;
MORPHOLINE DERIVATIVE;
THIOPHENE DERIVATIVE;
ANTICOAGULANT THERAPY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SAFETY;
HUMAN;
LETTER;
MEDICAL DECISION MAKING;
PRIORITY JOURNAL;
THROMBOSIS;
THROMBOSIS PREVENTION;
TOTAL KNEE REPLACEMENT;
TREATMENT OUTCOME;
VENOUS THROMBOEMBOLISM;
AFTERCARE;
DRUG ANTAGONISM;
KNEE ARTHROPLASTY;
NOTE;
PATIENT SELECTION;
RISK FACTOR;
THROMBOEMBOLISM;
AFTERCARE;
ANTICOAGULANTS;
ARTHROPLASTY, REPLACEMENT, KNEE;
DRUG MONITORING;
ENOXAPARIN;
FACTOR XA;
HUMANS;
MORPHOLINES;
PATIENT SELECTION;
RISK FACTORS;
THIOPHENES;
THROMBOEMBOLISM;
|
|
EID: 69249168317
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)61551-8 Document Type: Letter |
|
Times cited : (9)
|
|
References (4)
|
